Memory and plasma HVA changes in schizophrenia: are they episode markers?
Gilbertson
M W
MW
Department of Veterans Affairs Medical Center, Pittsburgh, PA.
Yao
J K
JK
van Kammen
D P
DP
D000328:Adult; D015415:Biomarkers / Q000097:blood; D003072:Cognition Disorders / Q000097:blood / Q000175:diagnosis / Q000523:psychology; D004311:Double-Blind Method; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006719:Homovanillic Acid / Q000097:blood*; D006801:Humans; D008297:Male; D011939:Mental Recall / Q000187:drug effects / Q000502:physiology*; D008875:Middle Aged; D009483:Neuropsychological Tests; D012008:Recurrence; D012559:Schizophrenia / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D012565:Schizophrenic Psychology; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000175:diagnosis / Q000523:psychology; D014888:Wechsler Scales
D015415:Biomarkers; D006220:Haloperidol; D006719:Homovanillic Acid